探討EGFR基因表現與合併藥物對攝護腺癌治療的影響(1/3)

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. ErbB Receptors 82%
3. Berberis 26%
4. Neoplastic Stem Cells 16%
5. Neoplasms 15%
6. Drug Resistance 14%
7. Prostate 13%
8. Down-Regulation 11%
9. Neoplasm Metastasis 9%
10. Apoptosis 9%
11. Bone and Bones 9%
12. Computational Biology 7%
13. Therapeutics 6%
14. Lung Neoplasms 6%
15. Signal Transduction 6%
16. Carcinogenesis 6%
17. Cell Survival 5%
18. Breast Neoplasms 5%